We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

195 hedge funds and large institutions have $1.51B invested in Olema Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $41.3M | Put options by funds: $11.1M

43% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 51

8% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 50

3% less funds holding

Funds holding: 200 → 195 (-5)

15.73% less ownership

Funds ownership: 132.15% → 116.42% (-16%)

33% less capital invested

Capital invested by funds: $2.27B → $1.51B (-$755M)

73% less funds holding in top 10

Funds holding in top 10: 11 → 3 (-8)

Holders
195
Holders Change
-5
Holders Change %
-2.5%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-72.73%
% of All Funds
0.04%
New
46
Increased
73
Reduced
51
Closed
50
Calls
$41.3M
Puts
$11.1M
Net Calls
+$30.2M
Net Calls Change
+$16.9M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$119M
2
State Street
State Street
Massachusetts
+$45.7M
3
SL
Siren LLC
Connecticut
+$32.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$25.6M
5
DFO
Duquesne Family Office
New York
+$22M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$28M
2
VPC
Vestal Point Capital
New York
-$27.2M
3
SC
Samlyn Capital
New York
-$26.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$23M
5
EAM
Eventide Asset Management
Massachusetts
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Pictet Asset Management
51
Pictet Asset Management
Switzerland
$3.24M -$6.36M -285,545 -57%
Victory Capital Management
52
Victory Capital Management
Texas
$3.04M +$2.62M +117,859 +137%
Bank of New York Mellon
53
Bank of New York Mellon
New York
$2.88M +$385K +17,282 +10%
Millennium Management
54
Millennium Management
New York
$2.73M -$7.02M -315,555 -63%
BFM
55
Boothbay Fund Management
New York
$2.6M -$990K -44,483 -20%
RSCM
56
Rock Springs Capital Management
Maryland
$2.54M +$1.61M +72,138 +73%
Deutsche Bank
57
Deutsche Bank
Germany
$2.41M +$2.19M +98,329 +156%
Hudson Bay Capital Management
58
Hudson Bay Capital Management
Connecticut
$2.31M +$3.45M +154,770 New
IHAM
59
Integral Health Asset Management
New York
$2.24M +$3.34M +150,000 New
PC
60
Pier Capital
Connecticut
$2.03M -$88.9K -3,993 -3%
Rafferty Asset Management
61
Rafferty Asset Management
New York
$1.96M +$1.93M +86,515 +192%
Invesco
62
Invesco
Georgia
$1.95M -$552K -24,799 -16%
JP Morgan Chase
63
JP Morgan Chase
New York
$1.92M -$2.8M -125,709 -47%
BGM
64
Burkehill Global Management
New York
$1.86M – – –
XT
65
XTX Topco
Cayman Islands
$1.84M +$2.74M +123,218 New
VOYA Investment Management
66
VOYA Investment Management
Georgia
$1.81M +$2.13M +95,503 +367%
HS
67
HighVista Strategies
Massachusetts
$1.75M -$2.76M -123,888 -51%
FISPB
68
Fideuram - Intesa Sanpaolo Private Banking
$1.74M +$2.52M +113,312 +3,237%
SPS
69
Susquehanna Portfolio Strategies
Pennsylvania
$1.7M -$167K -7,500 -6%
ACM
70
Aquatic Capital Management
Illinois
$1.66M +$2.13M +95,872 +626%
Prudential Financial
71
Prudential Financial
New Jersey
$1.64M +$2.45M +110,150 New
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.63M +$162K +7,260 +7%
TD Asset Management
73
TD Asset Management
Ontario, Canada
$1.58M -$672K -30,186 -22%
AllianceBernstein
74
AllianceBernstein
Tennessee
$1.45M -$106K -4,770 -8%
Ensign Peak Advisors
75
Ensign Peak Advisors
Utah
$1.44M +$2.15M +96,782 New
1 2
3
4 5

OLMA Hedge Fund Activity: Q1 2026 in Review

195 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2026, worth a combined $1.51B — down 33% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of OLMA and 46 opened new positions — a net loss of 4 holders — while 51 trimmed existing stakes and 73 added.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Franklin Resources, cutting an estimated $28M.

  • 195 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2026, down from 200 in Q4 2025.
  • Funds reported $1.51B of Olema Pharmaceuticals stock for Q1 2026, down 33% quarter-over-quarter.
  • 46 funds opened new Olema Pharmaceuticals positions in Q1 2026 and 50 closed out, a net change of -4 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2026 was Fidelity Investments, an estimated $119M added.
  • The largest Olema Pharmaceuticals seller in Q1 2026 was Franklin Resources, an estimated $28M sold.

Based on aggregated 13F filings for Q1 2026.